Mylan N.V today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the combination of Mylan and Upjohn, a division of Pfizer, which is expected to occur in mid-2020, subject to receipt of regulatory approvals, Mylan shareholder approval, and the satisfaction of other customary closing conditions. to its Board of Directors Published: May 12, 2020 at 9:51 a.m. ET Pfizer Inc. (NYSE: PFE) today announced the election of James Quincey to its Board of Directors, effective immediately. Dr. Hockfield is Professor of Neuroscience and President Emerita at the Massachusetts Institute of Technology (MIT). Mr. Quincey, age 55, was also appointed to the Compensation Committee and the Science and Technology Committee of Pfizer’s Board. Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Diane Jorkasky, M.D.

Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Hockfield to its Board of Directors, effective immediately. Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. Dr. Desmond-Hellmann, age 62, was also appointed to the Governance & Sustainability Committee and the Science and Technology Committee of Pfizer’s Board. to its Board of Directors GAITHERSBURG, Md., May 12, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a …

You may communicate with any of our directors, including the Lead Independent Director and the Audit Committee Chair, by writing to them c/o Margaret M. Madden, Senior Vice President and Corporate Secretary, Chief Governance Counsel at Pfizer Inc., 235 East 42nd Street, New York, New York 10017. Pfizer Inc. (NYSE: PFE) today announced the election of James Quincey to its Board of Directors, effective immediately. Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Desmond-Hellmann to its Board of Directors, effective immediately. NEW YORK--(BUSINESS WIRE)--April 02, 2020--Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Desmond-Hellmann to its Board of Directors, effective immediately. to its Board of Directors. PDA is pleased to announce the results of the 2020 Board of Directors and Officers election.

During a 16-year career with Pfizer Inc., Mr. Bagger served from 2006 to 2009 on Pfizer’s senior most management team as Senior Vice President, Worldwide Public Affairs and Policy. Dr. Hockfield, age 68, was also appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board. HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced the remaining appointees to the inaugural 13-member Board of Directors for Viatris, the new company that will result from the combination of Mylan and Upjohn, a division of Pfizer, which is expected to occur in mid-2020, subject … Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Desmond-Hellmann to its Board of Directors, effective immediately. Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D. 2020 Proxy Statement. to its Board of Directors Published: May 12, 2020 at 8:00 a.m. Press Release Altimmune Appoints Former Pfizer and GSK Executive Diane Jorkasky, M.D.
Purpose Blueprint; A Letter from Pfizer's Chairman & Chief Executive Officer; A Message from Pfizer's Lead Independent Director; Amended Notice of 2020 Annual Meeting and Supplement to Proxy Statement; 2019 Pfizer at a Glance; Table of Contents; Proxy Statement Summary; Item 1 - Election of Directors. Diane K. Jorkasky, M.D. to its Board of Directors Email Print Friendly Share May 12, 2020 07:00 ET | Source: Altimmune, Inc.